IMAX 配当と自社株買い
配当金 基準チェック /06
IMAX配当金を支払った記録がありません。
主要情報
n/a
配当利回り
0.4%
バイバック利回り
| 総株主利回り | 0.4% |
| 将来の配当利回り | 0% |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当と自社株買いの更新
Recent updates
IMAX (IMAX) Stock Could Be 5.3% Undervalued After Disclosure Day Opening Weekend
IMAX (IMAX) stock moved after Universal’s Disclosure Day delivered a robust opening weekend, with IMAX premium screens capturing nearly 15% of the film’s US$93.9 million global box office. See our latest analysis for IMAX. Beyond this weekend’s box office boost, IMAX’s recent share price momentum has been building, with a 30 day share price return of 33.97% and a 1 year total shareholder return of 51.82% reflecting how investors are reassessing both growth potential and risk. If this kind of...IMAX: Film Slate Management And Potential Sale Will Support Future Upside
The analyst price target for IMAX has increased from $47.00 to about $56.00, as analysts point to stronger margin potential, active film slate management and renewed interest following reports that the company is exploring a possible sale. Analyst Commentary Recent research has centered on how the current film slate, margin potential and potential corporate activity could affect the stock's valuation.IMAX: Premium Formats And Potential Sale Interest Will Drive Future Upside
Analysts have nudged their implied fair value estimate for IMAX higher from about $45.27 to $46.82, citing expectations for stronger revenue growth, higher forecast margins, and recent Street research that highlights potential corporate interest in the company. Analyst Commentary Recent Street research around IMAX reflects an active debate on valuation, execution, and potential corporate interest in the company.IMAX: Price Surge In Line With Buyout Expectations, But It's Not Pure Roses
Summary IMAX Corporation faces inflation-driven headwinds, but its diversified, quality-focused business model and digital adaptability provide resilience. Q1 2026 revenue declined 6% YoY to $81.38M, with operating margin dropping to 12.2% amid rising costs and softer demand. IMAX’s strategic partnerships with streaming platforms and customizable theater offerings help maintain demand and mitigate competitive and inflationary pressures. With $146M in cash, IMAX’s liquidity remains robust, but at ~$40 per share, valuation appears rich and already prices in potential buyout premiums. Read the full article on Seeking AlphaIMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power
The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside
The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk
Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.IMAX: Record Box Office And Premium Format Position Will Support Future Upside
The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk
The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.IMAX: Live Sports And Content Partnerships Will Support Future Upside
Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities
Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential
Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.IMAX: Premium Screens And Local Language Hits Will Support Future Upside
Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance
Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance
We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.IMAX: Future Box Office Releases And Network Expansion Will Shape Performance
IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance
The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.North America And Japan Installations Will Strengthen Premium Entertainment
Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.North America And Japan Installations Will Strengthen Premium Entertainment
IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued
Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear
Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema
Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking AlphaIs Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...IMAX Corporation: Overseas Growth Opportunities
Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking AlphaIMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar
The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential
Summary IMAX Corporation has a long growth runway in international markets, as the foreign markets' IMAX theater network penetration rate is lower than that for the US. IMAX can achieve higher profit margins in the future with rising top line contribution from alternative content that boosts the company's overall capacity utilization rate. IMAX stock is trading at below 1 times PEG, which implies that it is undervalued relative to its financial improvement potential. Read the full article on Seeking AlphaWhen Should You Buy IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it received a lot of attention from a substantial...Calculated Global Expansion And Innovative Content Slate Set To Propel Growth
IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings
Summary IMAX Corporation provides technology to movie theaters bringing an immersive experience, in part protecting the company from the rise of digital streaming platforms. After consistent backlog declines, IMAX finally reported great new signings in Q2, providing a great midterm growth outlook with a great new blockbuster movie pipeline. While IMAX's midterm growth outlook is great, the stock already prices in good growth, mitigating a very significant investment opportunity from the upbeat outlook. Read the full article on Seeking AlphaPinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now
When you see that almost half of the companies in the Entertainment industry in the United States have price-to-sales...Is IMAX (NYSE:IMAX) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...決済の安定と成長
配当データの取得
安定した配当: IMAXの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。
増加する配当: IMAXの配当金が増加しているかどうかを判断するにはデータが不十分です。
配当利回り対市場
| IMAX 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (IMAX) | n/a |
| 市場下位25% (US) | 1.4% |
| 市場トップ25% (US) | 4.2% |
| 業界平均 (Entertainment) | 1.6% |
| アナリスト予想 (IMAX) (最長3年) | 0% |
注目すべき配当: IMAXは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。
高配当: IMAXは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。
株主への利益配当
収益カバレッジ: IMAXの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。
株主配当金
キャッシュフローカバレッジ: IMAXが配当金を報告していないため、配当金の持続可能性を計算できません。
高配当企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/06/25 14:03 |
| 終値 | 2026/06/25 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
IMAX Corporation 11 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。20
| アナリスト | 機関 |
|---|---|
| Marla Backer | Ascendiant Capital Markets LLC |
| David McFadgen | ATB Cormark Historical (Cormark Securities) |
| Patrick Sholl | Barrington Research Associates, Inc. |